| Dr Casey John Goodhart, PHARM D | |
|
109 S Main St, Milbank, SD 57252-1806 | |
| (605) 432-5542 | |
| Not Available |
| Full Name | Dr Casey John Goodhart |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 109 S Main St, Milbank, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881188019 | NPI | - | NPPES |
| 6581 | Other | SD | SOUTH DAKOTA BOARD OF PHARMACY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6581 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Casey John Goodhart, PHARM D 109 S Main St, Milbank, SD 57252-1806 Ph: () - | Dr Casey John Goodhart, PHARM D 109 S Main St, Milbank, SD 57252-1806 Ph: (605) 432-5542 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. A report on the study, published online and in an upcoming issue of Annals of Neurology, raises questions about whether some generic products are safe and effective when a narrow dose range separates patients from help and harm.
GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.
Announcing a new article publication for Zoonoses journal. Researchers from Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Wuhan, China, University of Chinese Academy of Sciences, Beijing, China, Jinan University, Shenzhen, China and Shanghai Jiao Tong University School of Medicine, Shanghai, China consider dynamic surveillance of mosquitoes and their viromes in Wuhan during 2020.
Ligand Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for its proprietary Captisol-enabled Topiramate Injection for the treatment of partial onset or primary generalized tonic-clonic seizures in hospitalized epilepsy patients who are unable to take oral topiramate.
› Verified 9 days ago
Mr. Paul Arthur Sinclair, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 S Main St, Milbank, SD 57252 Phone: 605-432-9224 Fax: 605-432-6258 | |
Christina Hansen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 S Main St, Milbank, SD 57252 Phone: 605-432-5542 | |
Meredith Junker, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 S Main St, Milbank, SD 57252 Phone: 605-432-5542 | |
Laurie Ann Tennis, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 S Main St, Milbank, SD 57252 Phone: 605-432-5542 Fax: 605-432-5562 | |
Courtney Neubert, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 S Main St, Milbank, SD 57252 Phone: 605-432-5542 | |
Emily Jean Van Klompenburg, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 S Main St, Milbank, SD 57252 Phone: 605-432-5542 Fax: 605-432-6258 | |
Mrs. Rondi Scoular, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 S Main St, Milbank, SD 57252 Phone: 605-432-5542 Fax: 605-432-6258 |